Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Indirect Comparison of Darolutamide Versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate CancerJ Urol 2021 Aug 01;206(2)298-307, S Halabi, S Jiang, E Terasawa, V Garcia-Horton, R Ayyagari, AR Waldeck, N Shore
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.